22nd Century Group (NASDAQ:XXII) Given “Sell (E+)” Rating at Weiss Ratings

22nd Century Group (NASDAQ:XXII)‘s stock had its “sell (e+)” rating reaffirmed by equities researchers at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

Separately, StockNews.com lowered 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Stock Performance

XXII stock opened at $3.35 on Wednesday. The business’s 50-day moving average price is $5.02 and its two-hundred day moving average price is $23.49. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. The firm has a market cap of $5.76 million, a PE ratio of 0.00 and a beta of 1.57. 22nd Century Group has a 1-year low of $3.01 and a 1-year high of $581.85.

Institutional Trading of 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group at the end of the most recent reporting period. 18.06% of the stock is currently owned by institutional investors and hedge funds.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.